MSF Field Research > 1 Published Research and Commentary > HIV/AIDS > Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/88062
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!


Download this article:
View/Open File Description Size Format
Thumbnail
View/Open
Ford Lancet DOTS for ARV Review.pdf193KbAdobe PDF

Title: Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials.
Authors: Ford, Nathan
Nachega, Jean B
Engel, Mark E
Mills, Edward J
Affiliation: Médecins Sans Frontières, Cape Town, Western Cape, South Africa.
Citation: Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. 2009: Lancet
Journal: Lancet
Issue Date: 30-Nov-2009
URI: http://hdl.handle.net/10144/88062
DOI: 10.1016/S0140-6736(09)61671-8
PubMed ID: 19954833
Abstract: BACKGROUND: Directly observed therapy has been recommended to improve adherence for patients with HIV infection who are on highly active antiretroviral therapy, but the benefit and cost-effectiveness of this approach has not been established conclusively. We did a systematic review and meta-analysis of randomised trials of directly observed versus self-administered antiretroviral treatment. METHODS: We did duplicate searches of databases (from inception to July 27, 2009), searchable websites of major HIV conferences (up to July, 2009), and lay publications and websites (March-July, 2009) to identify randomised trials assessing directly observed therapy to promote adherence to antiretroviral therapy in adults. Our primary outcome was virological suppression at study completion. We calculated relative risks (95% CIs), and pooled estimates using a random-effects method. FINDINGS: 12 studies met our inclusion criteria; four of these were done in groups that were judged to be at high risk of poor adherence (drug users and homeless people). Ten studies reported on the primary outcome (n=1862 participants); we calculated a pooled relative risk of 1.04 (95% CI 0.91-1.20, p=0.55), and noted moderate heterogeneity between the studies (I(2)= 53.8%, 95% CI 0-75.7, p=0.0247) for directly observed versus self-administered treatment. INTERPRETATION: Directly observed antiretroviral therapy seems to offer no benefit over self-administered treatment, which calls into question the use of such an approach to support adherence in the general patient population. FUNDING: None.
Language: en
ISSN: 1474-547X
Rights: Reproduced on this site with permission of Elsevier Ltd. Please see http://www.thelancet.com/ for further relevant comment.
Appears in topics: HIV/AIDS

Related articles on PubMed
bullet
Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.
Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A
2007 Feb
bullet
bullet
bullet
bullet
See all 31 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Oct 23, 2014